No Data
No Data
Express News | The USA Biological Security Act was not included in the CR bill.
Hong Kong stocks fluctuation | Lepu Biotech-B (02157) surged over 18% in intraday trading; ADC reappears with significant overseas Trade, Institutions suggest great potential for TF ADC overseas authorization.
LePu Biotech-B (02157) rose by over 18% during the session. As of the time of writing, it is up 16.23%, priced at 3.08 Hong Kong dollars, with a transaction amount of 0.117 billion Hong Kong dollars.
Express News | Some Hong Kong pharmaceutical stocks are rising, with Lepu Biotech up nearly 6%.
The U.S. bioterrorism law has undergone significant changes, the CRO concept has launched a major counterattack, and WuXi AppTec is excited!
Industry pessimistic expectations may improve.
How to break through the challenges in the development of innovative drugs? The industry suggests focusing on internationalization.
① The year 2024 will be the inaugural year of large-scale authorized trade, and going abroad has become an important direction for the development of local pharmaceutical companies; ② Chinese企业品牌, clinical trial capabilities, data presentation formats, and levels of international operation still need time and practical verification.
Lepu Biopharma Renews Procurement Contract With Controlling Shareholder